Author Archives: medcon

Newsletter: Care.Data’s suspension enters the terrible twos

It’s 2 years to the day since Care.Data was suspended amongst public outrage. The failed programme is showing no signs of restarting, as NHS England and the Department of Health continue to sift through old pampers, and keep finding yet more problems.

The Caldicott Review of Consent, which began after NHS England lied to the Care.Data Advisory Group, should report soon, if those who want to water it down to avoid having to make uncomfortable decisions. Why might they do that? Well…

 

Another Jeremy Hunt promise is broken – Your Hospital Data is still being sold

Before their January deadline, HSCIC finished the testing needed to implement the hospital data consent promise that Jeremy Hunt made to every patient – which 1 million patients who opted out took him up on. The final step was for Jeremy Hunt to give the go ahead to keep his promise. He didn’t.

Let us be clear: Jeremy Hunt made the patient promise 2 years ago, and it appears in the 2015 conservative manifesto (pg 38) “We will give you full access to your own electronic health records, while retaining your right to opt-out of your records being shared electronically.” Only he can break his promise, and he has chosen to do so.

So when will the opt outs be implemented? We look forward to hearing any answer the ICO receive shortly on exactly that question, as they respond to our complaint. The Department of Health are refusing to answer questions – which is understandable as they don’t have any answers.

Your GP will honour your request for data not to leave your GP practice, both because of medical ethics and because of their direct connection to you. Who is Jeremy Hunt connected to?

The interim-type-2 opt out can be implemented tomorrow if Jeremy Hunt tells HSCIC to do it. Why hasn’t he?

You may wish to write to your MP, and ask the question, “when will the Secretary of State for Health implement patients’ choices to prevent data about them leaving the HSCIC for purposes beyond direct care?” – please also say why this matters to you. (and sorry the question is a bit of a mouthful)

This can be fixed. The Health Secretary just has to take the single action necessary to fix it, permanently.

A perfect overarching consent flag is something we support; but at best, it is a year away from being something a patient can ask their GP to do. No scenario, other than immediate implementation of the interim-type-2s, addresses the gap between now and then. A long-term maybe-mythical “perfect” solution is currently the weapon of choice of those who want to prevent any patient choice over data usage at all: that change being the consent choice (aka “interim-type-2”) which 1 million patients have requested be actioned, and that they are all waiting patiently for. When the first step down the path to consent has been taken for national datasets, there can be confidence that subsequent steps will be taken. If not, and the Department of Health breaks Jeremy Hunt’s promise this time, why should anyone believe them next time?

What’s next: Care.Data Everywhere?

On Friday, we’re expecting that Cabinet Office to launch their data copying consultation, which probably won’t have the subheading “care.data everywhere”, but unless they’ve fixed their compulsion to copy, it probably should have. It’s not all terrible news; the worst projects (probably) didn’t get this far – what the consultation will show is the stuff that they don’t think is terrible (that’s probably not reassuring).

Every project involved has had to explain how “it’s not like care.data because…”, but the Cabinet Office has seemingly learnt only the lessons convenient for them to learn. It’s hard to all learn the right lesson when institutional incentives encourage people to learn easier ones.

The lack of critical thought across the programme appears in Parliament’s report on the “Big Data Dilemma”, which says the NHS could save £66bn from more data copying. Saving about two thirds of the NHS budget (equivalent to getting rid of all staff from the NHS) seems… unlikely.

We’ll see what the Cabinet Office consultation says over the weekend, and any health implications will appear in the next newsletter. The Caldicott Review is also due to be consulted on, if it ever gets published.

What’s Next: Saatchi Bill returns to the Lords

With the most problematic bits of the bill removed by MPs, the Saatchi Bill on “medical innovation” is now a mechanism to create new databases, and do so only with the approval of Parliament.  How is this different to care.data, which Tim Kelsey repeatedly said was “the will of Parliament”?

That’s a very good question. The main difference is whether Parliament says yes, or whether it chooses not to say anything. Currently, silence means support, which was the approach that failed catastrophically with care.data.

We’ll be looking to have conversations with their Lordships about an amendment to require Parliament to approve any plans, rather than simply not objecting. Especially as this Government is looking to remove the ability for the Lords to object to anything…

More soon, and we especially thank all those who have made donations.

 

MedConfidential Christmas Bulletin: Freedom, Care.Data and Space

It’s been a busy few weeks, as the Government came back from Conference season, and kicked their various schemes into high gear. In 2016, we’ll see data sharing across the NHS and Government taking up time: care.data may become a ministerial playbook.

Your support is greatly appreciated; and thanks to you and your loved ones at this time of year. But here’s where we are at the moment, if you wish to delay Christmas cheer just a little longer:

Care.Data.

Care.Data’s still suspended while Dame Fiona Caldicott tries to unwrap Tim Kelsey’s leaving present. The programme will enter 2016 as it left 2014: still digging in deeper. A new leadership for care.data was an opportunity to change that approach.

We’ve heard secondhand that the a new Senior Responsible Owner, obliged to hold this poisoned chalice, has been handpicked from the few loyal bag carriers left in the care.data bunker. Which means he’ll have repeatedly made valiant attempts at defending the inept and the ill considered. Indeed, the job description practically required blindly ignoring the fact that the ship was sinking until bailed out by his boss. With the Admiral’s hat his to don, it’s interesting to see if it will be full steam ahead into the iceberg of public rejection, yet again.

Dame Fiona Caldicott’s review of consent reports at the end of January, with Ministerial decisions in the months after that. Past NHS management has been good at persuading ministers to put their reputation behind the publicly indefensible until it becomes evident, even to the Department of Health, that perhaps that was unwise. At the last Care.Data Advisory Committee meeting, it was grudgingly admitted that the September roll out was halted by Jeremy Hunt himself…

Given Cabinet level discussions about data sharing, and the scope of opt-outs and consent, 2016 should be a busy year for data in the NHS and beyond. It seems some see care.data as a model to be copied. As always, the first question is whether the Government or NHS England wishes to constructively engage, or cower in a corner and ignore those who will point out necessary implementation changes. That choice is entirely up to them.

Your Right To Know

The CoverUp Commission has found that the public quite like the ability to request copies of Government documents in acts of citizen driven focussed transparency. Thank you for helping with that…

MedConfidential submitted a brief note of our own experiences of FOI, and also a saveFOI.uk submission of 260 different successful FOI requests (or outcomes from multiple requests), many submitted by you and others. SaveFOI.uk submission asked a simple question: Which of these questions does Lord Burns think shouldn’t have been answered?

Power likes secrecy, and “Burns it” would have been a common refrain in Tim Kelsey’s archipelago of NHS England. Freedom of Information is how the details of care.data were forced to be published. The deep veil of official secrecy continues to hide the bulk of Tim Kelsey’s legacy, which hopefully will start to burn up over time.

Not everyone gets to be an astronaut.

Everyone in the NHS wants to help improve the health of the nation, but that’s not the same thing as giving Direct Care. In the same way, that lots of people helped put a man on the moon, without being an astronaut. Every child eventually learns that not everyone gets to be an astronaut; and sometimes it’s a hard transition.

Tim Kelsey, who wanted all to sell medical records before his term was out, leaves NHS England today to take up a new post in Australia, but assured us he “will be back”.

Transitioning to consensual, safe and transparent data handling practices is as important for a hospital as good cleaning or sterile instruments – and the same thing happens when you disregard it too much. “Sufficient” cleaning is too much of a burden until it’s self-evident that it was too little, and harm occurs. Hopefully, in 2016, NHS England will learn about data hygiene and air quality. The astronaut programme had the literal version of the same problem. Will there be a systematic response to a politically driven digital-MRSA infecting the NHS and beyond? If the problem is left to go away of its own accord, it always comes back.

Consensual, Safe and Transparent Christmas sharing

It’s been a busy few months, but we’re still here, and would like to continue to be. If you wish to support our work, a donation is always greatly appreciated.

With best wishes to and your loved ones for Christmas and for the new year. May 2016 bring consensual, safe and transparent data flows throughout the NHS and beyond.

See you next year – we really couldn’t do this without you. Best wishes to one and all.

Sam and Phil

Implementing Data Usage Reports

We introduced the concept of Data Usage Reports a year ago. Posting prototypes to officials unannounced led to a DH commitment for HSCIC to look at a roadmap for implementation.

3 weeks later, NHS England announced that they had done no work on implementing the care.data consent codes, and so transparency took a back seat to consent for most of the year. Not forgotten, not less important, just less urgent. Given that HSCIC only had 2 full time people working on either issue, this priority was clearly correct (although the hordes of staff digging care.data in deeper suggested a political allocation of resources).

As HSCIC moves towards an announcement on consent implementation in the new year (we have sent them some questions), it’s time to look at what we’ve learnt in a year of discussions about Data Usage Reports. Most of it is relatively dense detail, but the final section is the one missing piece.


It is necessary to close the Data Trust Deficit. The last year of work on Data Usage Reports, looking at all the details, shows this is entirely achievable, where there is political will.

Restating the Principle

You should have a complete knowledge of how individual level data about you has been used or disseminated. Any individual should be able to freely read the outcomes of those projects, the new research, the new knowledge, that they contributed to creating.

It’s that simple.
Continue reading

Electronic Health Records and Sharing along care pathways for direct care

 

The most important aspect of digital medical records is data flows along care pathways.  Despite all the political interest in care.data, and in secondary uses more widely, it is vital that clinically relevant medical information flows along care pathways where patients have not objected. It must be done consensually, safely, and transparently – and while the first two aspects of that considered in current implementations, they generally get stuck because there is no transparency in the system. Individual patient transparency should come via a data usage report, but that does not give the system an overarching view.

A systematic solution to transparency of the use of EHRs

For every organisation (or pathway, as relevant) that makes use of EHRs, there should be two figures added to NHS Choices:

  • % of inbound patients that receive records via EHR
  • % of outbound patients where records are sent via EHR

mockupCreated automatically off care provider systems, this should give a measure of how widely EHR transfer is used, rather than how often it could be used.
While a data usage report will tell an individual patient where their data has been used, this shows patients the level at which organisations are handing data off as patients move along care pathways.

       

medconfidential’s BMJ rapid response to “Slow and costly access to anonymised patient data impedes academic research”

Research is vital, and it is always unfortunate when any research project fails to deliver the promise in the funding proposal, irrespective of the reason. But railing against the custodian of the nation’s medical histories (BMJ 2015;351:h5087), the HSCIC, seems an odd choice if given any consideration.

The author’s institution was unable to give the assurances required that they were capable of looking after the data to the standard that the public expects. The standards have barely changed; what’s changed is that HSCIC has started checking the assurances more carefully – something it should have been doing all along.

Those necessary assurances are steered and delivered by institutions and supervisors on behalf of their students, not individual students themselves. It is not the students’ fault if their institution refuses to assure that it will take due care of 1 billion health events. And it is precisely the lack of verification of such assurances that sent 25 years of medical records to insurers, to marketers, and elsewhere.

Academia emerged with its reputation pretty much unscathed from the data debacles of 2014 and 2015. The high standards legitimate institutions expect of their researchers are one of the factors that justify the access to sensitive medical data, sometimes without consent, that academia is in a position to receive. Complaining that the standards are too high for your institution to agree to meet says more about the institution than the standards.

All research is important, but no single project – and no one institution – is more important than public confidence in all research. That is why a wide range of organisations support the “one strike principle for abuse or misuse of medical records. With the Hospital Episode Statistics, i.e. linked, longitudinal medical records of the population for the past 30 years, every woman with 3 children is uniquely identifiable – and with 2 children that’s about 90% likely (quite literally, a birthday attack).

In the last week, the ICO has fined the UK’s largest internet pharmacy for selling NHS patient and customer details to spammers, quacks and charlatans, pushing “innovative treatments and lottery scams (paragraphs 49, 51, 52). Those participating in the abuse of these records stand to make a great deal of money, and until there is a ban on marketing to patients that leads to jail time for these predators, there will continue to have to be deep scrutiny of every project, and every release.

The “promotion of health”, as undefined in the Care Act 2014, is a loophole so broad you could slip a Saatchi advertising hoarding through it, quacking.

The author’s experience is unfortunate. Both the researcher and their funder deserve a clear answer as to why their institution doesn’t provide them the infrastructure necessary for modern data-driven health research. But corners cannot be cut if patient confidence is to be maintained.

The care.data debacle includes lessons for many. While BMJ readers would always uphold the highest standards of Information Governance, readers may consider (former) colleagues who might – in similar or related circumstances – find themselves with a highly-cited paper, for all the wrong reasons?

HSCIC is the custodian of the nation’s medical histories. In making it available for legitimate research, it simply requires you fill in a form honestly. That shouldn’t be too high a bar*.

* Paragraph 62

-ENDS-

Excerpt from our last newsletter on the Saatchi/CHH bill:

medConfidential had some questions for Mr Heaton-Harris on the content of the draft Bill, and had a meeting with him last week. Our comments and suggestions arising from that meeting covered a ban on marketing to patientsData Usage Reports (including our example of what one might look like) and an alternative approach that might deliver the policy intent of the Bill without creating another new database, or giving DH duplicates of powers it already has.

 

[PRESS RELEASE] UK’s largest online pharmacy fined £130,000 for selling patients’ data to scammers

The Information Commissioner’s Office will this morning issue a £130,000 fine [1] to the UK’s largest NHS-approved online pharmacy, Pharmacy2U, [2] whose senior executives approved the sale of NHS patients’ and P2U customers’ personal data by direct marketers.

The ICO determined that, through a direct marketing company called Alchemy Direct Media (UK) Ltd, Pharmacy2U executives unlawfully and unfairly sold the personal data of over 21,000 NHS patients and P2U customers either directly, or through intermediaries, to:

  • Australian Lottery fraudsters [3] targeting male pensioners who were more likely to have chronic health conditions, or cognitive impairments;
  • a Jersey-based ‘healthcare supplement’ company [4] which the Advertising Standards Authority ruled against for “misleading advertising” and “unauthorised health claims”;
  • and a UK charity which used the details to solicit donations [5] for people with learning disabilities.

The ICO determined that the sale of personal data was “likely to cause substantial damage or substantial distress to the affected individuals”, [6] that the incidents were neither “one-off events or attributable to mere human error” [7] and that Pharmacy2U executives were negligent [8].

Phil Booth, coordinator of medConfidential said:

“When medConfidential made a complaint to the Information Commissioner on behalf of patients who were being marketed, we’d no idea the trade in their data was as murky as this.

“Vulnerable people shouldn’t be exposed to this sort of harm and distress, but what’s doubly appalling is that this was done by the largest NHS-approved online pharmacy in the country, which is part-owned by the company that provides a majority of GPs with their medical records systems.

“The Government has to act decisively. Six-figure fines alone won’t stamp out this poisonous trade; not when there’s so much profit to be made. There must now be a blanket, statutory ban on all marketing to patients.


“Those who profiteer from patients’ data are predators and should face prison when they are caught.”

Notes for editors:

  1. The fine is a ‘Monetary Penalty Notice’; the ICO’s full judgement is published here: https://ico.org.uk/action-weve-taken/enforcement/pharmacy2u-ltd/
  2. Following a Daily Mail investigation, first reported on 31 March 2015: http://www.dailymail.co.uk/news/article-3020480/Your-secrets-sale-NHS-dock-s-revealed-details-patients-bought-prescriptions-online-sold-off.html Pharmacy2U is 20% owned by EMIS, the single largest provider of GP IT systems across England, see p80: https://www.emisgroupplc.com/media/1084/emis-group-plc-annual-report-and-accounts-2014.pdf and EMIS’ current Chief Executive is also a Director of Pharmacy2U: https://www.companiesintheuk.co.uk/director/11692582/christopher-spencer
  3. See paragraphs 24-28 of the ICO’s judgement, which includes: “The National Trading Standards Scams Team has also informed the Commissioner’s office that the lottery company is the subject of an ongoing international criminal investigation into fraud and money laundering, although this wouldn’t have been known to Pharmacy2U.”
  4. See paragraphs 20-23, which includes: “In February 2015, the Advertising Standards Authority (“ASA”) issued an adjudication on Healthy Marketing Ltd in relation to breaches of the CAP Code, although this wouldn’t have been known to Pharmacy2U at the time the order was approved. The breaches related to a press advert which was found to contain misleading advertising and unauthorised health claims.”
  5. Paragraph 29 of the ICO’s judgement.
  6. Paragraph 65 of the ICO’s judgement.
  7. Paragraph 72 of the ICO’s judgement.
  8. Paragraph 63:  “The senior executive of Pharmacy2U must have known that there was a risk that people may object to the sale of data to the lottery company because, when he was asked to approve the order, he replied “OK but let’s use the less spammy creative please, and if we get any complaints I would like to stop this immediately”. However, he still approved the order.”

medConfidential campaigns for confidentiality and consent in health and social care, seeking to ensure that every flow of data into, across and out of the NHS and care system is consensual, safe and transparent. Founded in January 2013, medConfidential is an independent, non-partisan organisation working with patients and medics, service users and care professionals.

For further information or for immediate or future interview, please contact Phil Booth, coordinator of medConfidential, on 07974 230 839 or phil@medconfidential.org

– ends –

“Fair Processing” and the ICO

In practice, the ICO has a very simple test for fair processing:

Do data subjects know (i.e. have they been they fairly informed) what (processing of their data) you’re intending to do?

That’s it – is the organisation being completely honest?

If yes, that’s fair processing.

If no, that’s not “fair processing”.

It’s that simple. It’s not a high bar, and it’s not a complex bar.

If you end up in trouble, it’s because of surprises – you weren’t completely honest with the data subjects about what you were going to do.

With regard to fair processing, the ICO doesn’t make a distinction as to whether or not you should do something; it solely looks at whether you said you would. The ICO is often seen as facilitating data flows, because this test isn’t what people often seem to think it is.

The ICO considers itself to have one job in this regard, defined by the Data Protection Act, and that human rights are the remit of a Court. If someone is honest and informs you about using your data to breach your human rights, the ICO believes this is not a consideration for the data protection authorities. This may be an incomplete or incorrect reading of the law, but the current ICO has made its consideration.

In many controversial cases, organisations themselves – including the Government, Ministers, the NHS – all add additional requirements. These are not data protection constraints, they are moral constraints, they’re other legal constraints or they’re ‘ministerial gifts’ (e.g. the care.data opt out).

Remember, it’s only fair processing so long as what you tell people you’ll do matches what you actually do. (You can tell them you’ll do something and not do it – that’s still fair processing.)

When you want to do something new with data, if that wasn’t in the old rules, you need to tell people about the new rules. It is here that NHS England’s various data grabs have run into trouble, mainly because they don’t want to tell people quite what it is they want to do.

So in short, be completely honest.

No wonder the political machinations in the Department of Health and NHS England keep screwing it up…

P.S. Complaints about “fair processing” basically boil down to, “we don’t want to be honest with you”. Any fines simply show that you weren’t honest; one reason organisations get fined for losing data is because they’ve said that they won’t. If they didn’t say that, then losing your data mightn’t be a breach in those terms – but then no-one would do business with them. Which is why such promises get made in the first place.

[PRESS RELEASE] Kelsey leaves England for down under

medConfidential joins others in recognising the effect Tim Kelsey – Director for Patients and Information at NHS England, Chair of DH’s National Information Board, SRO for care.data and Chair of the care.data Programme Board – has had on the NHS.

Mr Kelsey announced today [1] that he will be resigning from NHS England and leaving the UK for Australia, to work as a commercial director for Telstra Health, a division of Australian telecommunications provider Telstra Corp – which in March this year acquired Dr Foster Intelligence [2], the company Mr Kelsey co-founded in 2000.

Tim’s commitment to the NHS is exemplified by serving his full notice period of 6 months. Earlier this morning, the HSCIC published its Board’s rejection of the Directions for the care.data pathfinders [3], a decision made in July.

Phil Booth, privacy advocate and long-standing scrutineer of Tim’s work, said:

“Tim’s gone back to his old job in the private sector, but serious questions of consent and transparency in NHS England remain unresolved. At the beginning of September Jeremy Hunt announced that responsibility for effective patient consent, long ignored by NHS England under Tim’s rule, had been handed to Dame Fiona Caldicott for resolution.

“We look forward to seeing how public confidence in the handling of NHS patient data will recover under new leadership. NHS England’s strident insistence on commercial re-use of medical records must now be reconsidered.

“Lord Saatchi’s Medical Database Bill, due to be re-published in the Commons the week after Conservative Party Conference, may provide some sign whether Jeremy Hunt has learnt the lessons of care.data for the entire NHS.”

Notes to editors:

1) NHS England announcement of Tim Kelsey’s resignation, 17/9/15: http://www.england.nhs.uk/2015/09/17/tim-kelsey-to-leave/

2) Telstra Health acquires Dr Foster Intelligence, 26/1/15: http://www.drfoster.com/updates/news/dr-foster-acquired-by-telstra-health/
Dr Foster Intelligence was formed when the Department of Health a 50% stake in Dr Foster in 2006, in a deal that was later criticised by the National Audit Office: http://www.nao.org.uk/report/dr-foster-intelligence-a-joint-venture-between-the-information-centre-and-dr-foster-llp/

3) Minutes of HSCIC Board meeting on 15/7/15, published on 17 September 2015, as part of papers for upcoming HSCIC Board meeting on 23/9/15. HSCIC reject the care.data Directions (previously approved by the care.data Programme Board and NHS England Board) for reasons listed on p10 of 300:

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/461371/20150923_HSCICBoardpapers_Part1.pdf

medConfidential campaigns for confidentiality and consent in health and social care, seeking to ensure that every flow of data into, across and out of the NHS and care system is consensual, safe and transparent. Founded in January 2013, medConfidential is an independent, non-partisan organisation working with patients and medics, service users and care professionals.

For further information or for immediate or future interview, please contact Phil Booth, coordinator of medConfidential, on phil@medconfidential.org

– ends –

Simon Says: Walk

NHS England and Rewired State recently ran a competition with a £30k prize fund for apps around obesity

We didn’t win a prize (they get announced next week), but http://simonsayswalk.com/ was our submission. 

“I know I should really go for a walk 3 times a week, but I’m just too busy…”

‘Middle-aged, managerial-class, overweight white man’ – let’s call him ‘David’ – knows he’s at risk of health complications from being overweight, he just doesn’t do anything about it for a host of legitimate reasons; he has meetings… he has dinners… he has an important job that puts many constraints on his time… he has a family with caring responsibilities…  (While we use a male example above, SimonSays:Walk is gender-indifferent)

This is not primarily an information problem amongst those who, over time, are likely to make disproportionate use of NHS services. SimonSays:Walk is designed to help people make a commitment; to schedule time to go for a walk.

Quite simply, SimonSays:Walk provides a ‘button’ people can press to add such a commitment to the calendar / electronic diary they already use (or which their personal assistant manages for them) on their smartphone, PC or tablet. Having made such a commitment, by reminding them and providing them with a simple map, SimonSays:Walk assists someone to get into the habit of taking regular walks.

The regular dates begin after a delayed start: the first appointment to walk will be scheduled two weeks ahead of the point at which someone first chooses to make a commitment. This will help make the decision to commit a bit easier – a decision with consequences two weeks in the future may be easier to make than one that imposes more immediate demands (this is, of course, testable) – and should help ease any diary issues / conflicts. It is also logical, on the basis that if someone decided to go for a walk today, a diary app wouldn’t be particularly helpful!

The use of the person’s existing electronic diary means appointments can be moved if necessary, and means that other people (e.g. personal assistant) with access to the person’s dairy can take account of other considerations and, hopefully, assist the individual to pick up the habit.

SimonSays:Walk is also ‘infinitely forgiving’; if you didn’t go for a walk today, there’s no shame other than that you impose on yourself – you can just go next time. (Someone else with access to your diary may be less forgiving, however!)

SimonSays:Walk does not aim to solve the whole problem of obesity; different people need different things. This tool is designed for those who are busy, and who use some form of electronic diary – though one need not necessarily be busy to make use of it.

In terms of functionality, if you are within a mile or so of an NHS pharmacy – which SimonSays:Walk  determines using open data from the NHS via data.gov.uk – it will suggest you may want to walk past it. We chose this particular function for a number of reasons: firstly, because NHS pharmacies tend to already have helpful information on display in their street-facing windows; and secondly, because those windows offer a low cost way to provide positive reinforcement for individuals who have engaged with the app, and also to promote (the goal of) SimonSaysWalk and the benefits of regular physical exercise more generally.

If the person is not that close to a pharmacy, there are probably nicer walks available. SimonSays:Walk suggests a direction and ‘walk radius’, not a specific route. Suggesting people walk through an industrial estate might not be sensible, or wise. In any case, it better for individuals – who are likely to know their immediate area better than an online tool – to make those decisions for themselves.

The simple premise of SimonSays:Walk is that it matters far less where you are, and exactly where you walk, than that you are sitting in a chair all day long. Any walk is better than no walk; this is about making it happen. When it’s in your diary that you use every day, you can make a commitment that it actually happens.

SimonSays:Walk adopts a privacy-preserving model – and using information and processes that people already use day-to-day – and tries to work with people’s lives, rather than trying to impose a major life change on them.

Once people become used to walking regularly, non-confidential phone calls, etc. could be done via mobile while going for a walk – or meetings could be scheduled about 25 minutes walk apart. We appreciate that in the UK, this would probably work better in the summer months.

If there is no GPS information available, e.g. from a non-location aware desktop browser, the map is centered on the pavement East of the Cenotaph, with a generic message about a walk.

People already have plenty of information that being overweight is bad for them; this is a tool to help them do something about it.

 

http://simonsayswalk.com/

Beach reading from medConfidential: a mid-August update

No newsletter this month, so we thought we’d do a quick round-up on the blog of some things you may wish to read, “chillaxing” on a beach.

What difference does 10% make?

Dribs and drabs of information about care.data are beginning to leak out. Many may have missed the Minister for care.data, George Freeman MP, give a very carefully couched answer to Parliament about the number of patients who have opted out.

As you may recall, the last time anyone said anything to Parliament directly was when Kingsley Manning suggested “about a hundred” patients have been affected by NHS England’s ‘Type 2’ cockup. His follow-up written answer “actually it’s more like 700,000” was somewhat buried by being published in the run-up to the Election.

Mr Freeman, however, had the more difficult task of announcing a much bigger number – which he did by the time-honoured tradition of hiding behind percentages and ranges. Even so, his answer meant we had to update our own estimate to between 950,000 and 1.6 million.

We had increased our estimate based on an extraordinarily detailed series of FOI requests by Dr Neil Bhatia, which he very kindly shared with us (and others). Dr Bhatia’s figures showed that – while what Mr Freeman told Parliament was true in as far as it went – the picture was somewhat more complex, possibly even alarming.

Mr Freeman limited his comments to a range which he said “the majority fall between 0.5 – 2.5%” opt outs. Dr Bhatia’s figures show quite a number of practices with opt outs in the 4 – 6% range, running as high as 12% or even 14% in a handful of practices. And don’t forget, these are the pathfinders – the volunteers, the supposedly keen practices. No one has detailed figures from any urban areas yet, as NHS England is still struggling to recruit practices in Leeds.

 

Talking more about care.data (not just on a beach)

One thing that does need to massively improve is the way that care.data is talked about.

NHS England is still far too fond of hiding its dodgy commercial re-use ambitions behind the figleaf of research. At the recent “son of care.data” events – officially, NIB ‘Work Stream’ 2.2 – the only secondary use that NHS England really wanted to talk about was research; offering very little to those asking “What about the other uses?”, such as commissioning.

If you happen to be planning a discussion of care.data after the holidays, here are some thoughts we hope are useful.

There are some sensible discussions going on, and a number of positive developments we hope will be announced in the months immediately following the summer – not least HSCIC’s ‘fix’ for the yet-to-be honoured ‘Type 2’ (9Nu4) opt outs. There are several legal instruments in the pipeline: new Directions for the care.data pathfinders and patient objections; CAG Regulations establishing promised safeguards and sanctions, and closing “the promotion of health” loophole; and hopefully, “at the earliest opportunity”, primary legislation to put the National Data Guardian on a statutory footing.

Let’s hope NHS England reflects over the summer on how little its ‘head down, keep people in the dark and keep rolling at all costs’ approach has achieved over the past 18 months – except further eroding public trust – and starts meeting some of the many promises it has made.

 

NHS Improvement

You may have missed the quiet announcement, just before Jeremy Hunt went off on his holidays, that DH’s troubled arm’s-length body, Monitor, and the NHS “Trust Development Agency” (that’s Trust as in NHS Trusts) are to merge, under the new brand “NHS Improvement”.

When it comes to Monitor’s worldview on data, things can only get better; it seems to have been taking care.data as a handbook, rather than as a salutary lesson. So the new NHS Improvement may provide a springboard for a huge leap forward. Or backwards, depending on crucial choices that must be made. Will they follow NHS England’s past-its-sell-by-date worldview, or the best thinking and actions of the reformed and reforming HSCIC – and what about patients? We’ve pondered the potential

Beyond this new merger, there are other areas that could be improved – not least the introduction of a data incident protocol aiming to provide patients in data crises with knowledge rather than media management, and to aspire to something more ethical than mere DPA-compliance. Also better consensual, safe and transparent sharing of medical records along care pathways, for patients’ direct care.

 

Use of data

With regard to the proper use of patient data, we’re still awaiting more details of what the high street pharmacies are looking to do with the Summary Care Record. Three were asked, two denied they were planning to abuse it. And our ‘old friends’ at PA Consulting have come out in their defence. (You may remember PA Consulting as the ones who made money uploading 25 years’-worth of our hospital data to Google, not to mention previous financial benefits from servicing the old Home Office ID cards scheme.)

One bright idea in the run-up to the Election by someone who probably hoped they’d never be responsible for implementing it – think mistakes like the Poll Tax – was to use people’s medical histories to deny them benefits. As we’ve discovered, sometimes “high level” political ideas interact badly on the ground; we wrote to David Cameron recently about just such an initiative, done in his name.

The Government gave the ‘employment problem’ to an Independent Review Panel, which currently has a consultation out. If you have a free moment, you may wish to respond to Question 7 (amongst others).

medConfidential is concerned that as DWP and HMRC are reengineered over the next 5 years, there’ll not only be more and more temptation, but a now practical ability to do similar things.

We would like to think that DWP and HMRC will take a decision that someone in the NHS is capable, though it seems to refuse to accept those same decisions when the professional outcome goes the other way. This type of discrepancy forms the basis for our draft submission to the Comprehensive Spending Review – if you have any comments, please e-mail them to coordinator@medconfidential.org

 

And finally…

In September, we’ll find out what happened when the deeply flawed Directions for the care.data pathfinders were considered by the HSCIC Board. If there were to be further delay, all the dates that NHS England has been announcing for the last month or more will have been misleading. Let’s hope NHS England didn’t screw anything up due to lack of consultation…

Phil’s on holiday for the next few weeks, so Sam’s really hoping NHS England doesn’t do anything catastrophically stupid before September. For that matter, NHS England probably is too…

 

We hope you enjoy your summer!
Sam and Phil